Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Eram Haider is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes
Cardoso, P., Young, K. G., Nair, A. T. N., Hopkins, R., McGovern, A. P., Haider, E., Karunaratne, P., Donnelly, L., Mateen, B. A., Sattar, N., Holman, R. R., Bowden, J., Hattersley, A. T., Pearson, E. R., Jones, A. G., Shields, B. M., McKinley, T. J., Dennis, J. M. (Lead / Corresponding author) & MASTERMIND consortium, May 2024, In: Diabetologia. 67, 5, p. 822-836 15 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile23 Link opens in a new tab Citations (Scopus)129 Downloads (Pure) -
Precision Medicine in Diabetes
Dawed, A. Y., Haider, E. & Pearson, E. R. (Lead / Corresponding author), 2023, Precision Medicine. Cascorbi, I. & Schwab, M. (eds.). Switzerland: Springer , p. 107-129 23 p. (Handbook of Experimental Pharmacology; vol. 280).Research output: Chapter in Book/Report/Conference proceeding › Chapter (peer-reviewed) › peer-review
-
Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine
Tobias, D. K., Merino, J., Ahmad, A., Aiken, C., Benham, J. L., Bodhini, D., Clark, A. L., Colclough, K., Corcoy, R., Cromer, S. J., Duan, D., Felton, J. L., Francis, E. C., Gillard, P., Gingras, V., Gaillard, R., Haider, E., Hughes, A., Ikle, J. M. & Jacobsen, L. M. & 31 others, , Oct 2023, In: Nature Medicine. 29, 10, p. 2438-2457 20 p.Research output: Contribution to journal › Review article › peer-review
172 Link opens in a new tab Citations (Scopus) -
Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review
Young, K. G., Haider McInnes, E., Massey, R. J., Kahkoska, A. R., Pilla, S. J., Raghavan, S., Stanislawski, M. A., Tobias, D. K., McGovern, A. P., Dawed, A. Y., Jones, A. G., Pearson, E. R. (Lead / Corresponding author), Dennis, J. M. (Lead / Corresponding author) & ADA/EASD PDMI, 5 Oct 2023, (E-pub ahead of print) In: Communications Medicine. 3, 20 p., 131.Research output: Contribution to journal › Article › peer-review
Open AccessFile25 Link opens in a new tab Citations (Scopus)101 Downloads (Pure)